Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in the development and deployment of vaccines against emerging viruses. Recommendations include (1) bolstering health information surveillance systems, (2) stakeholder engagement with health care, women, families and communities, and (3) changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health, and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
In this report, the National Vaccine Advisory Committee (NVAC) discusses maternal immunizations best practices, as well as gaps to implementation recommendations. One recommendation includes focusing efforts to improve financing for immunization services during pregnancy and the postpartum period. Public health and health care partners can support efforts promoting new payment and delivery models, patient-centered medical homes, and accountable care organizations. NVAC also recommends partnering with professional organizations and other maternal immunization stakeholders to develop toolkits and guidance for improving processes.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Data Collection Tool
The Coronavirus Perinatal Experiences Impact Survey (COPE-IS) is an assessment tool for new and expecting mothers that was built through a collaborative process with more than 100 scientists and clinicians involved. The tool focuses on experiences of new and expecting mothers, including exposure to COVID-19, financial considerations, social support, restricted activities, and coping.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Peer Review Study
Survey on the impact of COVID-19 on pregnant women that can be adapted to assessing the experiences of this population in future crises. This article discusses the findings of a survey distributed to 1,439 Dutch women who were pregnant between April 4-May 10, 2020. The survey included multiple scales, such as the COVID-19 and Perinatal Experiences scale, the State-Trait Anxiety Inventory, and the Edinburgh Depression Scale, and compared results with a similar survey completed in 2018. The survey included 8 key domain areas, including topics like financial stress, social support, partner support, anxiety symptoms, and depressive symptoms, to name a few. Women reported higher worries related to COVID-19 in general, and also reported higher work/financial related worries. Depression and anxiety also increased, with anxiety rates increasing two-fold.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report highlights the efficacy of COVID-19 mRNA vaccines (2-dose series) for pregnant mothers and their infants. In the aftermath of the Delta and Omicron waves, infants born to unvaccinated mothers were more likely to be among those hospitalized for COVID-19.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Systematic Review/Meta-Analysis
This review summarizes the factors contributing to COVID-19 inequities among immigrant communities. The review concludes with the overarching recommendation of engaging and empowering immigrant communities. Facilitating factors to address health inequities in this population include providing linguistically appropriate services, addressing poverty, and ensuring undocumented immigrants have access to public benefits.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Systematic Review/Meta-Analysis
This article summarizes considerations for COVID-19 prevention among migrant workers in meat processing plants. They review evidence on vaccinations, air filtration, masking, and other approaches.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Case Study
This case study outlines how the Cook County Department of Public Health (CCDPH) in Illinois partnered with community organizers on worker and immigrant rights to create a multisectoral collaborative to address root causes of health inequity called the Collaborative for Health Equity. This collaborative explicitly works to address structural racism and health inequities. It has built relationships with local social justice organizations that have helped guide CCDPH to center health equity in its strategic plans.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article reviews systemic factors affecting low income immigrant communities during COVID-19 and provides recommendations strategies to improve public health infrastructure using the Public Health 3.0 concept. This high-risk community represented a large portion of essential workers, who even before the pandemic faced less access to health care and were structurally marginalized. The authors discuss equity strategies including prioritizing COVID-19 public relief funds and allocating testing and vaccines to these communities. The paper also reviews how to improve public health infrastructure to mitigate disparities immigrant communities face by addressing social determinants of health, communicating about and structuring policies and programs that do not require identification, engaging cross-sector stakeholders, and developing tools to collect relevant, appropriate data.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study, Systematic Review/Meta-Analysis
The authors conducted a systematic review to understand disparities in H1N1 vaccine uptake by race/ethnicity, socioeconomic status, rural/urban residence, population density, and disability status, and factors associated with unequal uptake, as well as the benefits and harms of interventions designed to attenuate inequities in H1N1 vaccine uptake—in an effort to address potential disparities in COVID-19 vaccine access and uptake.